Rothschild & Co Wealth Management (UK)’s Pfizer PFE Stock Holding History

Rothschild & Co Wealth Management (UK)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,621	Closed	-$280K	–	47
2017 Q1	$280K	Buy	+8,621	New	+$272K	0.01%	29
2016 Q1	–	Sell	-692	Closed	-$21K	–	58
2015 Q4	$21K	Buy	+692	New	+$21.8K	﹤0.01%	38
2015 Q3	–	Sell	-6,889	Closed	-$219K	–	61
2015 Q2	$219K	Sell	6,889 -18,512	-73%	-$603K	0.02%	31
2015 Q1	$838K	Buy	25,401 +19,077	+302%	+$607K	0.09%	18
2014 Q4	$187K	Hold	6,324	–	–	0.02%	36
2014 Q3	$177K	Hold	6,324	–	–	0.02%	39
2014 Q2	$178K	Hold	6,324	–	–	0.02%	41
2014 Q1	$193K	Buy	+6,324	New	+$189K	0.02%	40

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild & Co Wealth Management (UK)'s PFE Position: Q2 2017 in Review

Rothschild & Co Wealth Management (UK) sold out of Pfizer (PFE) in Q2 2017, closing a stake of 8,621 shares — an estimated $280K sold.

Rothschild & Co Wealth Management (UK) first reported a position in PFE in Q1 2014 and held it in 8 quarters. The position peaked at $838K in Q1 2015. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Rothschild & Co Wealth Management (UK) reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Rothschild & Co Wealth Management (UK) sold 8,621 Pfizer shares in Q2 2017, an estimated $280K.
Rothschild & Co Wealth Management (UK) first reported a position in Pfizer in Q1 2014 and held it in 8 quarters.
Rothschild & Co Wealth Management (UK)'s Pfizer position peaked at $838K in Q1 2015.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Rothschild & Co Wealth Management (UK)'s 13F filing for Q2 2017, filed 19 Dec 2019.